Beth Israel Medical Center
New York, 10003, United States
NCT Number: NCT00206752
The purpose of this study is to assess the feasibility of avoiding opposite side neck radiation therapy in patients with clearly one side squamous cell cancer of the head and neck. We aim to assess the reduction in treatment volume (amount of radiation therapy required), and the resultant xerostomia and mucositis, with the delivery of unilateral neck radiation therapy.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
New York, 10003, United States
Patients will be treated with definitive external beam radiation plus/minus chemotherapy plus/minus neck dissection in the ipsilateral neck (post radiation). The primary site will be treated with definitive radiation therapy, or definitive surgery plus post-operative radiation therapy. Primary endpoints are loco-regional control, as well as quality of life, xerostomia, mucositis, and neck fibrosis.
Salivary evaluations shall be performed prior to the initiation of radiation therapy, during the second week of EBRT, and at the completion of radiation. Evaluations will also be conducted at 3, 6, and 12 months after the completion of EBRT.
Oral mucositis will be assessed prior to the initiation of EBRT and weekly during EBRT. Evaluations will also be conducted at 3 and 6 months after the completion of EBRT. Two standardized mucositis scales will be used: the RTOG scale and the WHO scale.
Clinical response will be evaluated by physical exam and PET/CT. PET/CT scans will be done at 3, 6, 12, 18, and 24 months, and then when clinically indicated during follow-up.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
definitive external beam radiation in the ipsilateral neck.
definitive external beam radiation in the ipsilateral neck
Time frame: September 2010
Beth Israel Medical Center
Other
A Randomized Prospective Evaluation of Unilateral/Ipsilateral Neck Irradiation in Selected Patients With Squamous Cell Carcinoma of the Head and Neck Who Are Managed by Radiation Therapy
Acronym: Unilateral
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04290546
Carcinoma, Carcinoma, Squamous Cell
Boston, Massachusetts, United States
View Trial DetailsNCT04609566
Bronchial Neoplasms, Carcinoma
Tucson, Arizona, United States
View Trial DetailsNCT04881045
Adnexal Diseases, Bronchial Neoplasms
Phoenix, Arizona, United States
View Trial DetailsNCT02841748
Carcinoma, Carcinoma, Squamous Cell
Atlanta, Georgia, United States
View Trial Details